Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
06:33pm, Saturday, 01'st May 2021
RADNOR, Pa., May 1, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Emergent BioSolutions
New York, New York--(Newsfile Corp. - May 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July
Emergent Biosolutions CEO walks back denial regarding cross contamination
04:01pm, Friday, 30'th Apr 2021
CNBC's Meg Tirrell reports Robert Kramer, the president and CEO of Emergent Biosolutions has walked back his comments on cross-contamination after denying it on CNBC TV.
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
02:35pm, Friday, 30'th Apr 2021
Emergent BioSolutions Inc (NYSE: EBS) has manufactured over 115 million doses of drug substance used in the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine, 60 million doses of which are in vials
Radnor, Pennsylvania--(Newsfile Corp. - April 30, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") that a securities
LOS ANGELES--(BUSINESS WIRE)---- $EBS #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 18, 2021 deadline to file a lead plaintiff motion in the class action
Los Angeles, CA ----(Newsfile Corp. - April 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions In
Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View
11:16am, Friday, 30'th Apr 2021
Emergent's (EBS) earnings in the first quarter of 2021 beat estimates while revenues miss the same. It lowers guidance for revenues from CDMO services.
New Strong Sell Stocks for April 30th
10:31am, Friday, 30'th Apr 2021
ARAY, EBS, FARM, SHLX, and TPB have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2021
Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript
12:23am, Friday, 30'th Apr 2021
Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript
NEW YORK, April 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 th
New Orleans, Louisiana--(Newsfile Corp. - April 29, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they hav
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
06:47pm, Thursday, 29'th Apr 2021
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of 57.73% and -6.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Emergent BioSolutions: Q1 Earnings Insights
05:03pm, Thursday, 29'th Apr 2021
Shares of Emergent BioSolutions (NYSE:EBS) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15200.00% over the past year to $1.53, whi
San Francisco, California--(Newsfile Corp. - April 29, 2021) - Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now.Class Period: Ju
